Camilo G Sotomayor1, António W Gomes-Neto2, Marco van Londen2, Rijk O B Gans3, Ilja M Nolte4, Stefan P Berger2, Gerjan J Navis2, Ramón Rodrigo5, Henri G D Leuvenink6, Casper G Schalkwijk7,8, Stephan J L Bakker2. 1. Division of Nephrology, c.g.sotomayor.campos@umcg.nl. 2. Division of Nephrology. 3. Department of Internal Medicine. 4. Department of Epidemiology, and. 5. Faculty of Medicine, Institute of Biomedical Sciences, University of Chile, Santiago, Chile; and. 6. Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. 7. Department of Internal Medicine and. 8. Cardiovascular Research Institute Maastricht School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, The Netherlands.
Abstract
BACKGROUND AND OBJECTIVES: In kidney transplant recipients, elevated circulating advanced glycation endproducts (AGEs) are the result of increased formation and decreased kidney clearance. AGEs trigger several intracellular mechanisms that ultimately yield excess cardiovascular disease. We hypothesized that, in stable kidney transplant recipients, circulating AGEs are associated with long-term risk of cardiovascular mortality, and that such a relationship is mediated by inflammatory, oxidative stress, and endothelial dysfunction biomarkers. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Prospective cohort study of stable kidney transplant recipients recruited between 2001 and 2003 in a university setting. We performed multivariable-adjusted Cox regression analyses to assess the association of AGEs (i.e., Nε -[Carboxymethyl]lysine (CML) and Nε -[Carboxyethyl]lysine (CEL), measured by tandem mass spectrometry) with cardiovascular mortality. Mediation analyses were performed according to Preacher and Hayes's procedure. RESULTS: We included 555 kidney transplant recipients (age 51±12 years, 56% men). During a median follow-up of 6.9 years, 122 kidney transplant recipients died (52% deaths were due to cardiovascular causes). CML and CEL concentrations were directly associated with cardiovascular mortality (respectively, hazard ratio, 1.55; 95% confidence interval, 1.24 to 1.95; P<0.001; and hazard ratio, 1.53; 95% confidence interval 1.18 to 1.98; P=0.002), independent of age, diabetes, smoking status, body mass index, eGFR and proteinuria. Further adjustments, including cardiovascular history, did not materially change these findings. In mediation analyses, free thiol groups and soluble vascular cell adhesion molecule-1 consistently explained approximately 35% of the association of CML and CEL with cardiovascular mortality. CONCLUSIONS: In stable kidney transplant recipients, circulating levels of AGEs are independently associated with long-term risk of cardiovascular mortality. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_09_17_CJN00540119.mp3.
BACKGROUND AND OBJECTIVES: In kidney transplant recipients, elevated circulating advanced glycation endproducts (AGEs) are the result of increased formation and decreased kidney clearance. AGEs trigger several intracellular mechanisms that ultimately yield excess cardiovascular disease. We hypothesized that, in stable kidney transplant recipients, circulating AGEs are associated with long-term risk of cardiovascular mortality, and that such a relationship is mediated by inflammatory, oxidative stress, and endothelial dysfunction biomarkers. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Prospective cohort study of stable kidney transplant recipients recruited between 2001 and 2003 in a university setting. We performed multivariable-adjusted Cox regression analyses to assess the association of AGEs (i.e., Nε -[Carboxymethyl]lysine (CML) and Nε -[Carboxyethyl]lysine (CEL), measured by tandem mass spectrometry) with cardiovascular mortality. Mediation analyses were performed according to Preacher and Hayes's procedure. RESULTS: We included 555 kidney transplant recipients (age 51±12 years, 56% men). During a median follow-up of 6.9 years, 122 kidney transplant recipients died (52% deaths were due to cardiovascular causes). CML and CEL concentrations were directly associated with cardiovascular mortality (respectively, hazard ratio, 1.55; 95% confidence interval, 1.24 to 1.95; P<0.001; and hazard ratio, 1.53; 95% confidence interval 1.18 to 1.98; P=0.002), independent of age, diabetes, smoking status, body mass index, eGFR and proteinuria. Further adjustments, including cardiovascular history, did not materially change these findings. In mediation analyses, free thiol groups and soluble vascular cell adhesion molecule-1 consistently explained approximately 35% of the association of CML and CEL with cardiovascular mortality. CONCLUSIONS: In stable kidney transplant recipients, circulating levels of AGEs are independently associated with long-term risk of cardiovascular mortality. PODCAST: This article contains a podcast at https://www.asn-online.org/media/podcast/CJASN/2019_09_17_CJN00540119.mp3.
Authors: A M Schmidt; O Hori; J X Chen; J F Li; J Crandall; J Zhang; R Cao; S D Yan; J Brett; D Stern Journal: J Clin Invest Date: 1995-09 Impact factor: 14.808
Authors: Wolfgang C Winkelmayer; Matthias Lorenz; Reinhard Kramar; Manuela Födinger; Walter H Hörl; Gere Sunder-Plassmann Journal: Am J Transplant Date: 2004-07 Impact factor: 8.086
Authors: Katrien H J Gaens; Gijs H Goossens; Petra M Niessen; Marleen M van Greevenbroek; Carla J H van der Kallen; Hans W Niessen; Sander S Rensen; Wim A Buurman; Jan Willem M Greve; Ellen E Blaak; Marc A van Zandvoort; Angelika Bierhaus; Coen D A Stehouwer; Casper G Schalkwijk Journal: Arterioscler Thromb Vasc Biol Date: 2014-04-10 Impact factor: 8.311
Authors: Katrien H J Gaens; Isabel Ferreira; Marjo P H van de Waarenburg; Marleen M van Greevenbroek; Carla J H van der Kallen; Jacqueline M Dekker; Giel Nijpels; Sander S Rensen; Coen D A Stehouwer; Casper G Schalkwijk Journal: Arterioscler Thromb Vasc Biol Date: 2015-10-08 Impact factor: 8.311
Authors: Maja Dodig Novaković; Sanja Lovrić Kojundžić; Mislav Radić; Marijana Vučković; Andrea Gelemanović; Marija Roguljić; Katja Kovačević; Josip Orešković; Josipa Radić Journal: J Pers Med Date: 2022-06-16
Authors: Josipa Radić; Marijana Vučković; Andrea Gelemanović; Ela Kolak; Dora Bučan Nenadić; Mirna Begović; Mislav Radić Journal: Int J Environ Res Public Health Date: 2022-09-04 Impact factor: 4.614